NIH Shrinks Tumors with Immunotherapy, ADHD Medications Show Benefits Over Risks, Scientists Decode E. coli Toxin, Study Urges Climate Model Overhaul, and more...
Apr 07, 2025•11 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
NIH Breakthrough: Personalized Immunotherapy Shrinks Tumors in GI Cancer Patients Amid Staffing Challenges
Study Finds ADHD Medications' Benefits Outweigh Cardiovascular Risks Amid Rising Prescriptions
Scientists Decode E. coli's Deadly Toxin, Paving Way for Targeted Treatments Amid Antibiotic Resistance
Study Reveals Aerosols' Cooling Effect on Climate Greater Than Expected, Urges Climate Model Overhaul
Study Unveils Thalamus's Key Role in Conscious Awareness, Challenging Traditional Cortex-Centric Views
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Study Finds ADHD Medications' Benefits Outweigh Cardiovascular Risks Amid Rising Prescriptions
Scientists Decode E. coli's Deadly Toxin, Paving Way for Targeted Treatments Amid Antibiotic Resistance
Study Reveals Aerosols' Cooling Effect on Climate Greater Than Expected, Urges Climate Model Overhaul
Study Unveils Thalamus's Key Role in Conscious Awareness, Challenging Traditional Cortex-Centric Views
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
For the best experience, listen in Metacast app for iOS or Android